Form 4: Beta Bionics Director, Danny L. Dearen, Acquires Shares Through Restricted Stock Unit Award

Danny L. Dearen, a director at Beta Bionics, acquired 11,247 shares of common stock through a restricted stock unit award on March 15, 2025.

Summary

• On March 15, 2025, Danny L. Dearen, a director of Beta Bionics, Inc. [BBNX], acquired 11,247 shares of common stock.
• The acquisition was made through a restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
• The price per share was $0.
• Following the transaction, Dearen directly owns 11,247 shares of Beta Bionics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a transaction. The acquisition of shares by a director is generally viewed as a slightly positive signal, but it's not a major event.

Positives

• The acquisition of shares by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Key Dates